NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma has closed its trading window for insiders starting July 1, 2026, in line with SEBI insider trading rules. The window will remain shut until 48 hours after the company announces its Q1 FY27 (quarter ending June 30, 2026) unaudited financial results. The restriction applies to directors, designated employees, their immediate relatives, and all connected persons covered under the company's insider trading code. The board meeting date to declare the Q1 results has not yet been disclosed and will be communicated later.
This is a routine compliance announcement and not an investment signal in itself. It does mean Q1 FY27 results are expected in the coming weeks, which could be a near-term catalyst for the stock.